A letter of response to comments on 'A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers'.

[1]  J. Raoul,et al.  A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers. , 2020, European journal of cancer.

[2]  R. Diasio,et al.  Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5‐Fluorouracil Therapy , 2018, Clinical pharmacology and therapeutics.

[3]  M. Pocard,et al.  Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study , 2018, Annals of Surgical Oncology.

[4]  S. Yokoyama,et al.  Factors Influencing the Appearance of Oxaliplatin-Induced Allergy. , 2017, Biological & pharmaceutical bulletin.

[5]  W. Solass,et al.  Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis , 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[6]  D. Elias,et al.  Results of Two Bi-Institutional Prospective Studies Using Intraperitoneal Oxaliplatin With or Without Irinotecan During HIPEC After Cytoreductive Surgery for Colorectal Carcinomatosis , 2011, Annals of surgery.

[7]  D. Elias,et al.  Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis. , 2003, Surgical oncology clinics of North America.

[8]  G. Milano,et al.  Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity , 2002, British Journal of Cancer.

[9]  J. Pignon,et al.  Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  J. Jolivet.  Role of leucovorin dosing and administration schedule. , 1995, European journal of cancer.